Articles tagged "Retransplantation"

2021 American Transplant Congress
Comparison of Donor-derived Cell Free Dna Between Recipients with First Solitary Allograft and Regrafts
S. Paluri¹, S. Muthusamy¹, M. Shinbashi¹, G. Gupta¹, B. Dale², Z. Kashi³, P. Halloran⁴, D. Kumar¹
¹Virginia Commonwealth University, Richmond, VA, ²CareDx, Brisbane, CA, ³Kashi Clinical Laboratories, Portland, OR, ⁴ATAGC, Edmonton, AB, Canada
*Purpose: Donor derived-cell free DNA (dd-cfDNA) is a biomarker of immunological injury. Multiple studies have validated its utility in recipients of first solitary kidney transplants…
2021 American Transplant Congress
Immunosuppression Impacts Panel Reactive Antibody Status in Second Solid Organ Transplant Recipients – A Single Center Experience
J. Patel¹, S. Ali², M. L. Sanders¹, C. P. Thomas¹, D. Axelrod¹, M. Bilal³, E. H. Field³, S. Kuppachi¹
¹University of Iowa Hospitals & Clinics, Iowa city, IA, ²Louis A. Johnson VA Medical Center, Clarksburg, WV, ³Iowa City VA Health Care System, Iowa city, IA
*Purpose: Patients who require a second solid organ transplantation are significantly disadvantaged due to the event of sensitization due to the first transplant. We hypothesized…
2021 American Transplant Congress
Continuation of Immunosuppression After the First Renal Allograft Failure Impacts Panel Reactive Antibody Status During Subsequent Renal Transplantation
J. Patel¹, S. Ali², M. L. Sanders³, C. P. Thomas³, D. Axelrod³, M. Bilal⁴, E. H. Field⁴, S. Kuppachi³
¹University of Iowa Hospitals & Clinics, Iowa CIty, IA, ²Louis A. Johnson VA Medical Center, Clarksburg, WV, ³University of Iowa Hospitals & Clinics, Iowa City, IA, ⁴Iowa City VA Health Care System, Iowa City, IA
*Purpose: The standard of care following renal allograft failure is to discontinue immunosuppression (IS) to limit risks from further IS. We hypothesized that continuation of…
2021 American Transplant Congress
Donor-Derived Cell-Free DNA Performance Characteristics are Similar for Repeat and Primary Kidney Transplant Recipients
V. R. Peddi¹, S. Akkina², S. C. Jordan³, W. Tian⁴, Y. Qazi⁵
¹California Pacific Medical Center, San Francisco, CA, ²Loyola University Medical Center, Maywood, IL, ³Cedars-Sinai Medical Center, Los Angeles, CA, ⁴CareDx, Brisbane, CA, ⁵University of Southern California, Los Angeles, CA
*Purpose: Repeat kidney transplants (RKT) represent 12.4% of kidney transplants (KT) (10.9% of all living donor and 13.6% of all deceased donor). Most RKT are…
2021 American Transplant Congress
Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States
S. Riad¹, G. Larrieux², S. Jackson³, R. Kandaswamy²
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, M-Health Fairview, Minneapolis, MN
*Purpose: Failed kidney allograft is the fourth leading indication for kidney transplantation. A significant portion of second kidney transplant recipients undergo preemptive transplantation while on…
2021 American Transplant Congress
Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States
S. Riad¹, T. Shaker¹, S. Jackson², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, M-Health Fairview, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: A failed kidney allograft is the 4th leading indication for kidney transplantation. We examined the association of induction use in 2nd kidney transplant recipients…
2021 American Transplant Congress
Graft Loss in Adolescent and Young Adult Generation After Pediatric Kidney Transplantation: A Single Center Experience in Japan
Y. Aoki, Y. Hamasaki, M. Muramatsu, J. Hashimoto, M. Kubota, S. Shishido, K. Sakai
Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: Kidney transplant recipients of all ages may have difficulty adhering to a strict treatment plan, adolescents and young adults are at particularly high risk…
2021 American Transplant Congress
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation
H. Fernandez, A. Wall, A. Gupta, E. Martinez, J. Bayer, G. McKenna, N. Onaca, R. Ruiz, C. Spak, G. Testa
Baylor University Medical Center, Dallas, TX
*Purpose: Hepatic artery thrombosis (HAT) is a severe complication in liver transplantation (OLTX). Re-OLTX for patients with HAT has been met with controversy due to…
2021 American Transplant Congress
Update on Pancreas Retransplantation- A Registry Analysis
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: A successful pancreas transplant provides patients with brittle diabetes the opportunity of good long-term metabolic control. While initially more and more retransplants were performed,…
2020 American Transplant Congress
Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series
J. G. Guorgui¹, T. Ito¹, M. M. Lu¹, P. Benharash², A. Ardehali³, V. Gudzenko⁴, C. Wray⁴, V. G. Agopian¹, J. DiNorcia III¹, H. Yersiz¹, D. G. Farmer¹, R. W. Busuttil¹, F. M. Kaldas¹
¹The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Cardiovascular Outcomes Research Laboratories, UCLA, Los Angeles, CA, ³Division of Cardiac Surgery, Department of Surgery, UCLA, Los Angeles, CA, ⁴Department of Anesthesiology, UCLA, Los Angeles, CA
*Purpose: Extracorporeal Membrane Oxygenation (ECMO) is a life-saving treatment modality for patients who develop cardiopulmonary failure refractory to conventional efforts. ECMO has been used sparingly…